Why We Rebuilt Januvia
19:43–20:47 · 64s
LC explains the bold decision to replace an award-winning asymmetric hydrogenation route for sitagliptin with a new strategy, setting up a rethink of optimization versus true route innovation.
19:43–20:47 · 64s
LC explains the bold decision to replace an award-winning asymmetric hydrogenation route for sitagliptin with a new strategy, setting up a rethink of optimization versus true route innovation.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.